CompletedNCT02488720

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study

Studying Amyloidosis

Last synced from ClinicalTrials.gov May 3, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Southern California
Principal Investigator: Reisa Sperling, MD
Center for Alzheimer Research and Treatment Brigham and Women's Hospital
Enrollment: 538 enrolled
Eligibility: 65-85 years · All sexes
Timeline: 2015 – 2023

Study locations (30)

University of Alabama, Birmingham, Birmingham, Alabama, United States
Banner Alzheimer's Institute, Phoenix, Arizona, United States
Banner Sun Health Research Institute, Sun City, Arizona, United States
University of California, Irvine, Irvine, California, United States
University of Southern California, Los Angeles, California, United States
University of California, Los Angeles, Los Angeles, California, United States
VA Palo Alto HSC / Stanford School of Medicine, Palo Alto, California, United States
Yale University School of Medicine, New Haven, Connecticut, United States
Georgetown University, Washington D.C., District of Columbia, United States
Howard University, Washington D.C., District of Columbia, United States
Mayo Clinic, Jacksonville, Jacksonville, Florida, United States
Wien Center for Clinical Research, Miami Beach, Florida, United States
Synexus Clinical Research, Orlando, Florida, United States
University of South Florida - Health Byrd Alzheimer Institute, Tampa, Florida, United States
Synexus Clinical Research - The Villages, The Villages, Florida, United States
+15 more locations on ClinicalTrials.gov

Collaborators

Alzheimer's Association · National Institute on Aging (NIA) · Alzheimer's Therapeutic Research Institute

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02488720 on ClinicalTrials.gov

Other trials for Amyloidosis

Additional recruiting or active studies for the same condition.

See all trials for Amyloidosis →

← Back to all trials